Calcimimetics versus parathyroidectomy: What is preferable?

Secondary hyperparathyroidism (SHPT) is common among patients with end-stage renal disease (ESRD). SHPT is associated with high-turnover bone disease, interstitial and vascular calcifications, cardiovascular morbidity and mortality. The pharmacological management of SHPT has progressed in recent yea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International urology and nephrology 2018-07, Vol.50 (7), p.1271-1275
Hauptverfasser:	Rroji, M., Spasovski, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Bone turnover Calcimimetic Agents - therapeutic use Calciphylaxis Calcium Cardiovascular diseases Cinacalcet Hydrochloride - therapeutic use Dialysis Drug therapy End-stage renal disease Female Glands Humans Hyperparathyroidism Hyperparathyroidism, Secondary - drug therapy Hyperparathyroidism, Secondary - etiology Hyperparathyroidism, Secondary - surgery Hypocalcemia Intolerance Kidney diseases Kidney Failure, Chronic - complications Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - therapy Kidney transplantation Male Medicine Medicine & Public Health Morbidity Mortality Nephrology Nephrology - Review Parathyroid Parathyroid hormone Parathyroidectomy Parathyroidectomy - methods Patients Prognosis Quality of life Renal Dialysis - methods Risk Assessment Treatment Outcome Urology Vitamin D Vitamin D receptors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!